Then, six collagen genes (COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, and COL5A2) were selected for further validation in Oncomine, TCGA (The Cancer Genome Atlas), and CGGA (Chinese Glioma Genome Atlas) database. This evidence concerns the gene COL5A2 and central nervous system cancer.